Cargando…
Fortified phosphorus-lowering treatment through administration of lanthanum protects against vascular calcification via regulation of FGF23 in chronic kidney disease
Phosphorus reduction can prevent against vascular calcification (VC) in chronic kidney disease (CKD), but the mechanisms underlying its actions remain unclear. The aim of the present study was to determine the effect of a fortified phosphorus-lowing treatment on VC in CKD. Serum levels of creatinine...
Autores principales: | Jiang, Jie, Li, Yi, Zheng, Dongwen, Wang, Zhen, Zhou, Hongmei, Liu, Guohui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521475/ https://www.ncbi.nlm.nih.gov/pubmed/32901861 http://dx.doi.org/10.3892/ijmm.2020.4719 |
Ejemplares similares
-
Energy-dense diets increase FGF23, lead to phosphorus retention and promote vascular calcifications in rats
por: Raya, Ana I., et al.
Publicado: (2016) -
Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function
por: Lindberg, Karolina, et al.
Publicado: (2013) -
Metabolomics of clinical samples reveal the treatment mechanism of lanthanum hydroxide on vascular calcification in chronic kidney disease
por: GU, Chao, et al.
Publicado: (2022) -
Understanding the Stony Bridge between Osteoporosis and Vascular Calcification: Impact of the FGF23/Klotho axis
por: Wei, Xu, et al.
Publicado: (2021) -
The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease
por: Chen, Yan, et al.
Publicado: (2021)